We have described two types of oligosaccharide modification influencing the antigenicity of the herpes simplex virus type 1 (HSV-1)-specified glycoprotein C (gC-1). First, the expression of several epitopes belonging to antigenic site II of gC-1 is dependent on the peripheral galactose of N-linked oligosaccharides. We have also shown that treatment of HSV-1-infected cells with 5-n-propyl-2'-deoxyuridine (PdU) under certain circumstances results in other modifications of peripheral carbohydrate determinants, which are associated with increased antigenic activity of gC-1. In the present study we have mapped and characterized the epitopes susceptible to PdU induction by analysing the reactivity to a number of monoclonal antibodies defining several epitopes of antigenic sites I and II. The results indicate that the strict galactose dependence of epitopes and the PdU-induced increase of antigenic activity are independent and unrelated phenomena. Thus, we identified galactose-dependent epitopes that were not PdU-inducible and vice versa, and some epitopes were both galactose-dependent and PdUinducible. The results support a model where PdU treatment blocks synthesis of an antigen-masking carbohydrate determinant. In addition, PdU treatment of HSV-l-infected cells seemed to increase the antigenic activity of other HSV-1 glycoproteins.
Introduction
The carbohydrates of a viral glycoprotein may influence its immunological properties in two opposite ways. On the one hand, peripheral carbohydrate determinants may diminish the effect of the immunological response by masking potentially neutralizing epitopes (Skehel et al., 1984; Sj6blom et al., 1987; Huso et al., 1988) . On the other hand, a degree of glycosylation may be necessary to generate and maintain an appropriate antigenic protein conformation (Alexander & Elder, 1984; Sj6blom et al., 1987; . We have identified two modifications of the peripheral carbohydrates of proteinlinked oligosaccharides which are associated with alterations of the antigenic activity of the herpes simplex virus type 1 (HSV-1)-specific glycoprotein C (gC-1). (i) Removal of penultimate or terminal fll-4-1inked galactose residues of N-linked oligosaccharides results in a drastic decrease in the antigenic activity of epitopes of antigenic site II, a carbohydrate-rich region of gC-1. However, another family of epitopes situated in a less glycosylated region (site I) are not affected by removal of these galactose residues (Sj6blom et al., 1987; . (ii) Treatment of HSV-l-infected cells with 5-n-propyl-2'-deoxyuridine (PdU) results in the modification of glycosylation associated with an increase in the availability of gC-1 to hyperimmune rabbit antisera. The PdU-induced modifications are a decrease in sialylation and galactosylation of O-linked oligosaccharides and a decrease in sialylation and in the branching of N-linked oligosaccharides (Olofsson & Datema, 1990 ). This effect is obtained in cell culture if the nucleoside analogue is added after initiation of DNA synthesis.
The aims of the present paper were (i) to define the location of PdU-inducible epitopes, (ii) to determine whether they were identical to the galactose-dependent epitopes, previously described by us (Sj6blom et al., 1987; and (iii) to determine whether the epitopes arose by demasking or induction. This was accomplished by analysing the reactivity of gC-1 obtained from PdU-treated HSV-l-infected cells against a panel of monoclonal antibodies which defined physically mapped epitopes of gC-l.
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Methods
Virus and cells. The HSV-1 strain F and African green monkey kidney cells, strain AH1 (GMK) (Giinalp, 1965) , were used throughout the study.
Drugs, chemicals and radiochemicals. PdU was kindly supplied by Dr D. Shugar, Polish Academy of Sciences, Warsaw, Poland. For metabolic labelling of HSV-l-infected cells, D-[6-3H]glucosamine hydrochloride (specifc activity 29 Ci/mmol) obtained from Amersham was used. All reagents and solvents were of reagent grade.
Preparation ofimmunosorbent-purified gC. The details for production of immunosorbent-purified gC have been reported previously (Olofsson et al., 1983) . Briefly, a membrane fraction from HSV-l-infected cells was produced by the method of Springer et al. (1977) . This fraction was solubilized in 0-l M-glycine buffer pH 8.8 containing 1-0 % (w/v) Triton X-100 and centrifuged at 100000 g for 1 h. The solubilized glycoproteins were subjected to affinity chromatography using the gCspecific monoclonal antibody B1C1 coupled to CNBr-activated Sepharose, as previously outlined (Olofsson et al., 1983) . The purified glycoprotein was subjected to SDS-PAGE and was found to migrate as a single band corresponding to an apparent Mr of 130K.
Monoclonal andpolyclonal antibodies. The rabbit antisera specific for individual HSV glycoproteins were prepared by immunizing rabbits with immunosorbent-purified HSV glycoproteins as previously described for the gC-specific antiserum designated K642 (Olofsson et al., 1983) .
The mouse monoclonal antibodies C1, C3, C8, C11 and C13 (ascites fluids) defining individual epitopes of antigenic sites I or II, and characterized with respect to mapping positions (Marlin et al., 1985) and the carbohydrate-dependence of their epitopes (Sj6blom et al., 1987) , have been described previously. The mouse monoclonal antibodies designated B1C1 and C2H12 were produced and characterized as described (Olofsson et aL, 1983; Sj6gren-Jansson & Jeansson, 1985; Sj6blom et al., 1987) . These monoclonal antibodies were propagated in cell culture by a dialysis tubing method (Sj6gren-Jansson & Jeansson, 1985) permitting antibody concentrations (1 to 5 mg/ml) equivalent to those obtained by the ordinary ascites method. A summary of the characteristics of the epitopes investigated in the present study is presented in Fig. 3 .
Epitopes recognized by particular monoclonal antibodies are referred to with the prefix 'Ep' in combination with the designation of the monoclonal antibody.
Radioimmunoprecipitation assay (RIPA) evaluation of antigenicity.
Petri dish (50 mm) cultures of GMK-AH1 cells were infected with 10 p.f.u./cell of HSV-1. The cells were treated with nucleoside analogues from 6 h post-infection (p.i.), radiolabelled with [3H]GlcN at 7 h p.i. and harvested at 18 h p.i. The cells were lysed in 1 ml TBS containing 1% Triton X-t00 and insoluble material was pelleted by centrifugation at 100000 g for 1 h. The amount of radioactivity precipitable with gCspecific antibodies was determined as detailed below according to Olofsson et al. (1983 Olofsson et al. ( , 1986 .
The reaction mixture, consisting of 25 ~tl of cell extract and 5 Ixl of antiserum (standard condition), was incubated at 4 °C for 1 h. In some experiments higher as well as lower concentrations of antibodies were investigated. Thereafter, 100 p.l of washed, heat-fixed staphylococci (10% v/v suspension) was added and the mixture was incubated at 4 °C for 1 h under gentle agitation. The staphylococci were washed twice in TBS, containing 1% Triton X-100, 0.1% BSA and then twice in TBS without any detergent. Radiolabelled glycoproteins were released from the staphylococci by boiling in electrophoresis sample buffer (0-0625 MTris pH 6.8, 10 % v/v glycerol, 2 % SDS, 5 % v/v 2-mercaptoethanol) and d.p.m, values were calculated after liquid scintillation counting. For analysis of mouse monoclonal antibodies, staphylococci coated with excess rabbit anti-mouse IgG (Dako Immunoglobulins) were used. The proportions of antigen and antibody were optimized according to Horowitz & Scharff (1969) .
Periodate treatment and enzyme-linked assays. Sequential removal of carbohydrates from gC-I coated on microplates was carried out as previously described (Sj6blom et al., 1987) . Polystyrene microplates (A/S Nunc) were coated with purified preparations of gC-1 in 0.1 Msodium carbonate buffer pH 9-6 (100 ~tl per well) by incubation for 2 h at 37 °C. In most experiments the coating concentration of gC-I was 0.25 p.g/ml. The plates were subsequently treated with 50 ~tl of sialidase [Behringwerke; 100 milliunits (mU)/ml] in 50mi-sodium acetate buffer pH 5.5, containing 9 mM-CaCI2 at 37 °C for 2 h and thereafter with serial dilutions of sodium periodate (in 50 mM-sodium acetate buffer, pH 4.5) according to Woodward et aL (1985) . The plates were subsequently incubated with mouse monoclonal antibodies against gC-1. The reactions were visualized as described below. All serum dilutions used in this assay were optimized by chequerboard titrations in which the antigen coating concentration and the antibody dilution were varied (Sj6blom et al., 1987) .
The effect of the combined sialidase-periodate treatment on the oligosaccharide side-chains was determined by the use of biotinylated Ricinus communis lectin (RCA) (Sj6blom et al., 1987) . The reactions were visualized by addition of alkaline phosphatase-conjugated avidin (lectin assay; Jackson Immune Research) at 0.5 ~tg/ml in PBS, or goat antibodies against mouse IgG (antibody assay; Jackson Immune Research) diluted 1/1000 in PBS. The plates were read at 405 nm after addition of alkaline phosphatase substrate (Sigma) at 1 mg/ml in 1 Mdiethanolamine buffer pH 9.8.
Results
In a previous report we showed that the antigenicity of gC-1, expressed as its reactivity with a polyclonal gCspecific rabbit antiserum designated K642, was increased if the glycoprotein had been produced in the presence of PdU. This was not due to a PdU-induced de novo synthesis of gC-1 but to changed immunological properties of gC-1 (Olofsson & Datema, 1990) . The increased antigenicity was observed as an increased amount of immunoprecipitable gC-1 with a rabbit gCspecific hyperimmune serum (Fig. 1) . The distribution of fluorographic density in the electropherogram demonstrated that the increase in antigenicity correlated with a heavily stained gC band, which migrated slightly faster than the fully glycosylated gC-1 expressed in untreated cells.
To determine whether the PdU-induced increase of antigenicity involved site I or site II epitopes, we analysed the reactivity of a panel of monoclonal antibodies defining epitopes from either of the two antigenic sites (Fig. 2) . We used the same radioimmunoprecipitation protocol as that used for evaluation of the polyclonal serum (Olofsson & Datema, 1990) . PdU treatment of HSV-1-infected cells at concentrations up to 25~tg/ml resulted in production of gC-1 with an increased reactivity against antibodies C 1, C8 and C 13, whereas the reactivity against antibodies C3 and B1C1 was not significantly increased. The behaviour of antibody C11 was variable. As demonstrated in Fig. 2 , the observed induction of antigenic activity ranged from an increase of about 7 0~ for EpC13 to a threefold increase in the activity of EpC1. A comparison of the results of the present paper and the previous results by Sj6blom et al. (1987) regarding removal of peripheral fl 1-4-1inked galactose (summarized in Fig. 3 ) demonstrated that these treatments affected the epitopes differently. Thus, we found PdU-inducible epitopes that were not galactose-dependent and vice versa, indicating that the galactose dependence and PdU inducibility of antigenic effects are independent phenomena.
To ensure that the differences observed between PdUinducible and non-inducible epitopes were specific and not caused by differences in epitope saturation, we performed a classical saturation analysis according to Horowitz & Scharff (1969) with different antibody concentrations. Analysing glycoproteins produced in the absence of PdU, we found that the amount of gC-1 precipitated by any of the monoclonal antibodies reached a broad plateau maximum spanning the antibody addition range from 0-2 ~1 to 10 ~tl of antibody fluid. The results from one PdU-inducible and one noninducible epitope are shown in Fig. 4 . At antibody additions above this range the amount of gC-I precipitated decreased due to the excess of antibody. We found that the patterns of PdU-inducibility and non-inducibility were reproducible within a 50-fold antibody concentration range for all epitopes investigated. This indicated (1983) , and the shaded box denotes the positions of multiple clustered short O-linked glycans (Olofsson et al., 1983; Lundstr6m et al., 1987) . The mapping of galactose-dependent epitopes (defining monoclonal antibody designation given) is based on the report by Sj6blom et al. (1987) .
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that the differences observed (Fig. 2) for different epitopes were due to PdU-induced changes in the intrinsic properties of gC-I and not to differences in antibody saturation or other restrictions of the experimental system. The question arose of whether the PdU-induced change in oligosaccharide structure implied removal of a carbohydrate determinant which was hiding an inducible epitope, or whether the altered carbohydrate structure induced a change in the three-dimensional structure of gC-l. The newly characterized monoclonal antibody, C2H12, was considered to be a suitable probe for experiments to answer this question, as this antibody recognizes a continuous epitope which is independent of the three-dimensional conformation of gC-1 (I. Sj6blom et al., unpublished results). This epitope is situated within antigenic site II or close to it (I. Sj6blom et al., unpublished results). If EpC2H12 was found to be inducible by PdU treatment, it could be concluded that PdU, at least in some cases, induced antigenic activity by the unmasking of cryptic epitopes. RIPA experiments similar to those depicted in Fig. 2 showed that PdU treatment significantly increased the amount of gC-1 available for this antibody (Fig. 5 c) . This indicated that the PdU-induced enhancement could be caused by the demasking of cryptic epitopes. We also determined whether the newly characterized epitope recognized by monoclonal antibody C2H 12 was dependent on galactose, as was shown for the other epitopes of this region (Sj6blom et al., 1987) . Purified gC-1 was coated onto microtitre plates and subjected to a treatment designed to remove peripheral sugars from oligosaccharides in a sequential and controlled manner (see Methods). As expected from previous experiments (Sj6blom et al., 1987) , the reactivity of EpBIC1, the control, decreased concomitantly with the RCA-binding activity, confirming the galactose dependence of this epitope (Fig. 5 b) . In contrast, EpC2H12 maintained its reactivity even at very high concentrations of periodate, indicating that this epitope was independent of peripheral carbohydrate determinants for its expression (Fig.  5a ). As outlined in Fig. 3 , this is the first epitope in this region of gC-1 that is not modulated by galactose residues of adjacent oligosaccharides.
If demasking EpC2H 12 is a major mechanism behind PdU-inducible antigenicity, then essentially all gC-1 molecules should expose non-inducible epitopes such as EpB1C1 and EpC3 in the absence of PdU. In other words, at saturating concentrations of antibodies B1C1 and C3, the amount of precipitable gC-1 should be significantly larger than the amount of gC-1 precipitated by monoclonal antibodies recognizing PdU-inducible epitopes. Accordingly, we found that the maximum amount of gC-1 precipitated was at least three times higher for antibodies B1CI and C3 than that obtainable with antibodies reacting with PdU-inducible epitopes (Fig. 6 ). These data support the hypothesis that the PdUinduced increase of antigenicity involves the recruitment of epitopes which were previously hidden by carbohydrates in the majority of gC-1 molecules.
If the PdU induction of gC-1 antigenicity reflects a general masking activity by N-linked oligosaccharides, it 1 and 3) of PdU. PdU and radioisotope were added as described in Methods. Antisera K861 (lanes 1 and 2) and K169 (lanes 3 and 4) were obtained after immunization with immunosorbent-purified gB or gD. After RIPA the precipitates were subjected to SDS-PAGE and subsequent fluorography, as previously described (Olofsson et al., 1983) .
should be possible to increase the antigenic activity of other HSV-1 glycoproteins by PdU treatment. To evaluate this possibility we subjected gB-1-or gD-1-specific polyclonal antisera (obtained by immunizing rabbits with purified preparations of the two glycoproteins) to RIPA with glycoprotein extracts from untreated and PdU-treated HSV-l-infected cells (Fig. 7) . It was found that the amounts of gD-1 precipitated with monospecific rabbit antisera were increased after PdU treatment. No significant corresponding increase was found with the antibody specific for gB-1. However, examining the SDS-polyacrylamide gel of the precipitate obtained with the gD-specific rabbit antibody (Fig.  7, lanes 3 and 4) it is evident that there is a band at the gB position, the intensity of which is increased after PdU treatment. This finding suggests that this serum, in addition to the large amounts of gD-specific antibodies, also contained small amounts of gB-specific antibodies which obviously reacted with PdU-inducible gB epitopes. These data suggest that gD-1 at least contains a significant number of epitopes inducible by PdU.
Discussion
The main conclusion of the present paper is that modification of terminal glycosylation by PdU treatment of HSV-l-infected cells is associated with a selective induction of certain epitopes of gC-1. We have previously shown that periodate-induced or enzymic removal of penultimate//l-4-1inked galactose residues is associated with a decrease in the antigenic activity of certain epitopes (Sj6blom et al., 1987; . The data of the present paper demonstrate that these two types of carbohydrate-induced antigenicity are independent, i.e. a//1-4-galactose-dependent epitope may or may not be PdU-inducible and vice versa (summarized in Fig.  3 ). It is interesting that the galactose-dependent epitopes were all situated in the highly glycosylated N-terminal portion of gC-1 ( Sj6blom et al., 1987) , whereas the present data show that PdU-inducible epitopes were also situated in antigenic site I, which is located in the less glycosylated C-terminal half of gC-1 (Fig. 3 ). These data demonstrate that peripheral carbohydrate structural determinants of gC-1 oligosaccharides may modulate the antigenic activity of the glycoprotein by at least two different and independent mechanisms. Whereas the galactose-dependent modulation of antigenicity is associated with one single well defined carbohydrate determinant , the PdU-induced changes in glycosylation are more heterogeneous, consisting of (i) a decrease in sialylation and galactosylation of O-linked oligosaccharides and (ii) a decrease in sialylation and the branching of N-linked oligosaccharides (Olofsson & Datema, 1990) . There are, however, reasons to believe the change in N-glycosylation is of major importance for the modulation of antigenic activity. Thus EpC1 [indistinguishable from EpC2/4 described by Wu et al. (1990) ], which is situated in antigenic site I distant from the peptide stretch harbouring the majority of O-linked carbohydrates (Olofsson et al., 1986; Lundstr6m et al., 1987) , was found in the present study to be induced markedly by PdU treatment of HSV-l-infected cells (Fig. 2a) . However, Pro 373, which constitutes a structural determinant of this epitope, is separated by only nine amino acid residues from the only N-linked glycan situated in the peptide stretch harbouring antigenic site I (Wu et al., Frink et al., 1983) . In contrast, EpC11, which was not easily inducible by PdU treatment, has not been mapped closer than some 60 amino acid residues (Gin 307) to the particular N-glycosylation site (Wu et al., 1990) .
The present data demonstrate that some epitopes, such as EpC8 and EpC13, are both galactose-dependent and PdU-inducible. This implies that the PdU-induced removal of masking determinants must be compatible with the preservation of at least some fll-4-1inked galactose residues of N-linked oligosaccharides. Moreover, this assumption is compatible with the presence of significant amounts of galactose, as determined by its reactivity with RCA in gC-1 from PdU-treated cells (Olofsson & Datema, 1990) . Galactose occurs in Nlinked oligosaccharides as a penultimate sugar (Kornfeld & Kornfeld, 1976 ) and consequently, the only possible changes in glycosylation compatible with normally galactosylated N-linked oligosaccharides should be inhibition of fucosylation, addition of sialic acid or oligosaccharide branching (Schachter, 1986) . Inhibition of fucosylation could be excluded as this sugar is essential for lentil lectin binding , a property which in fact was increased by PdU treatment (Olofsson & Datema, 1990) . The idea that the decreased degree of oligosaccharide branching generated by PdU treatment of HSV-l-infected cells is a cause of the increased antigenicity is therefore attractive in many respects.
One explanation for the complex influence of carbohydrates on the antigenicity of gC-1 could be that the physical epitopes recognized by some of the antibodies constitute carbohydrate determinants. Such carbohydrate epitopes, recognized by heterophilic antibodies, have been demonstrated for certain retroviruses (L6wer et al., 1981) . However, several lines of both direct and circumstantial evidence indicate that the gC-1 epitopes analysed in the present paper are of a peptide and not a carbohydrate nature. (i) It was not possible to block antibody binding to gC-1 even with high concentrations of monosaccharides (Sj6blom et al., 1987) . (ii) Experiments with gC-1 expressed in galactosyltransferasedeficient mouse neuroblastoma cells have shown that peripheral fucose units of N-linked glycans may replace the Gal(//1-4)GIcNAc determinant as a promoter of EpB1C1 antigenicity . It seems very unlikely that a methylated sugar with the Lconfiguration (fucose) could replace an unsubstituted Dhexose (galactose) as part of an antibody-binding determinant. (iii) If carbohydrate structures constituted epitopes, at least some of the monoclonal antibodies recognizing gC-1 should bind to other HSV glycoproteins, as these proteins are glycosylated by the same glycosyltransferases as gC-1 .
The galactose dependence of epitopes seems to correlate with stabilization of an antigenic three-dimensional conformation (Sj6blom et al., 1987; , whereas the present study suggests that much of the antigenicity-enhancing effect of PdU was due to demasking of epitopes hidden by peripheral carbohydrate determinants. This idea is also consistent with the suggestion that the increase in antigenic activity is caused by changes in the branching of oligosaccharides. The simplest model explaining the complex pattern of differentially modulated carbohydrate epitopes in gC is that PdU-sensitive, multi-branched N-linked oligosaccharides, recognized by their affinity for the leucoagglutinating Phaseolus vulgaris lectin (Olofsson & Datema, 1990) , exerted an umbrella effect and covered peptide epitopes. This is consistent with the preservation of galactose-dependent epitopes, provided that sufficient galactose-containing biantennary oligosaccharides resist the PdU treatment. This model is compatible with the current understanding of the conformation of glycoprotein oligosaccharides in solution and their interactions with the peptide backbone (for a review, see Montreuil, 1987) . Thus, the various branches of N-linked oligosaccharides have different degrees of molecular flexibility; some branches are flexible with the ability to fold backwards against the polypeptide surface and others are more rigid and are exposed farther from the peptide surface. Therefore, a PdU-induced decrease in branching could result in the disappearance of distally exposed branches with masking effects, concomitant with preservation of flexible branches, allowing antigenicity-promoting carbohydrate-protein interactions.
